By Denise Mann
HealthDay Reporter
MONDAY, March 5 (HealthDay News) — For years, women with the severe form of premenstrual syndrome known as premenstrual dysphoric disorder (PMDD) were told that their symptoms should subside the day menstruation begins.
Now, new research suggests that these symptoms, which can include serious mood swings, start about four days before menstruation and can linger through the first three days of menses — as many women with the disorder can attest.
MONDAY, March 14 (HealthDay News) — Women may be less likely to develop premenstrual syndrome if they eat a diet rich in two types of B vitamins, a new study suggests.
Women who consumed thiamine (B1) and riboflavin (B2) in their food significantly reduced their risk of PMS, the data suggested. Thiamine is found in fortified cereals, whole grains, beans and nuts, and researchers said eating two to three servings of thiamine-rich foods a day appeared to thwart PMS.
TUESDAY, March 23 (HealthDay News) — A new drug shows promise in treating severe menstrual cramps, researchers say.
The condition, called dysmenorrhea, affects 45 percent to 90 percent of women of child-bearing age and is the leading cause of school and job absenteeism among women in their teens and 20s, according to a news release from the American Chemical Society. Existing treatments, such as pain relievers, anti-inflammatory drugs and oral contraceptives, are ineffective in nearly one-third of women with moderate to severe dysmenorrhea, the news release noted. Read More
TUESDAY, Dec. 22 (HealthDay News) — Along with preventing pregnancy, hormonal contraceptives also treat menstruation-related disorders such as severe menstrual pain and heavy menstrual bleeding, according to a new Practice Bulletin issued by the American College of Obstetricians and Gynecologists.
The bulletin also said that combined contraceptives containing both estrogen and progesterone reduce the risk of endometrial, ovarian and colorectal cancer. Other potential benefits include prevention of menstrual migraines, treatment of pelvic pain caused by endometriosis and treatment of bleeding because of uterine fibroids. Read More
MONDAY, May 4 (HealthDay News) — Relapse is common among women with severe premenstrual syndrome (PMS) who stop taking the antidepressant sertraline to treat their symptoms, a new study concludes.
It included 174 women with PMS or the most severe form of PMS — premenstrual dysphoric disorder (PMDD). The women were randomly assigned to take sertraline for four months and then switch to placebo for 14 months or to take sertraline for 12 months and a placebo for six months. Read More
WEDNESDAY, July 30 (HealthDay News) — Researchers have uncovered a potential cause for postpartum depression, at least in mice. Read More
| Text Size: |  |
|
